Similar articles

• A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations.

  Zabetian CP, Samii A, Mosley AD, Roberts JW, Leis BC, Yearout D, Raskind WH, Griffith A. Zabetian CP, et al. Neurology. 2005 Sep 13;65(5):741-4. doi: 10.1212/01.wnl.0000172630.22804.73. Neurology. 2005. PMID: 16157909
• LRRK2 gene in Parkinson disease: mutation analysis and case control association study.

  Paisán-Ruíz C, Lang AE, Kawarai T, Sato C, Salehi-Rad S, Fisman GK, Al-Khairallah T, St George-Hyslop P, Singleton A, Rogaeva E. Paisán-Ruíz C, et al. Neurology. 2005 Sep 13;65(5):696-700. doi: 10.1212/01.wnl.0000167552.79769.b3. Neurology. 2005. PMID: 16157901
• LRRK2 mutations in Parkinson disease.

  Farrer M, Stone J, Mata IF, Lincoln S, Kachergus J, Hulihan M, Strain KJ, Maraganore DM. Farrer M, et al. Neurology. 2005 Sep 13;65(5):738-40. doi: 10.1212/01.wnl.0000169023.51764.b0. Neurology. 2005. PMID: 16157908
• [Pathogenesis of Parkinson's disease through LRRK2 mutation].

  Ohta E, Obata F. Ohta E, et al. Seikagaku. 2014 Feb;86(1):92-7. Seikagaku. 2014. PMID: 24693706 Review. Japanese. No abstract available.
• LRRK2 and Parkinson disease.

  Dächsel JC, Farrer MJ. Dächsel JC, et al. Arch Neurol. 2010 May;67(5):542-7. doi: 10.1001/archneurol.2010.79. Arch Neurol. 2010. PMID: 20457952 Review.